{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:31:49Z","timestamp":1794573109174,"version":"4.9.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clineuro.2024.108251","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T20:34:59Z","timestamp":1710966899000},"page":"108251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effectiveness of Levetiracetam versus phenytoin in preventing seizure in traumatic brain injury patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1558-4817","authenticated-orcid":false,"given":"Armin","family":"Karamian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Farzaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5252-1631","authenticated-orcid":false,"given":"Mojtaba","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-5041","authenticated-orcid":false,"given":"Ali","family":"Seifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clineuro.2024.108251_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1177\/0963689717714102","article-title":"Traumatic brain injury: current treatment strategies and future endeavors","volume":"26","author":"Galgano","year":"2017","journal-title":"Cell Transpl."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108251_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","article-title":"The epidemiology and impact of traumatic brain injury: a brief overview","volume":"21","author":"Langlois","year":"2006","journal-title":"J. Head. Trauma Rehabil."},{"key":"10.1016\/j.clineuro.2024.108251_bib3","unstructured":"Peterson, A.Bea Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths, United States, 2014. 2014."},{"issue":"No. SS-9","key":"10.1016\/j.clineuro.2024.108251_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6609a1","article-title":"Traumatic brain injury\u2013related emergency department visits, hospitalizations, and deaths \u2014 United States, 2007 and 2013","volume":"66","author":"Taylor CA","year":"2017","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.clineuro.2024.108251_bib5","doi-asserted-by":"crossref","unstructured":"Gl\u00f6tzner, F.L., et al., [Seizure prevention using carbamazepine following severe brain injuries]. Neurochirurgia (Stuttg), 1983. 26(3): p. 66-79.","DOI":"10.1055\/s-2008-1053615"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108251_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1042-3680(18)30745-9","article-title":"Management of head injury. Posttraumatic seizures","volume":"2","author":"Temkin","year":"1991","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"s10","key":"10.1016\/j.clineuro.2024.108251_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1528-1157.44.s10.4.x","article-title":"Epidemiology of posttraumatic epilepsy: a critical review","volume":"44","author":"Frey","year":"2003","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108251_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/neu.2015.4131","article-title":"Levetiracetam treatment in traumatic brain injury: operation brain trauma therapy","volume":"33","author":"Browning","year":"2016","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108251_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the management of severe traumatic brain injury","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108251_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/01.WNL.0000031432.05543.14","article-title":"Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the quality standards subcommittee of the American academy of neurology","volume":"60","author":"Chang","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108251_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1310\/hpj4809-757","article-title":"Retrospective analysis of Levetiracetam compared to phenytoin for seizure prophylaxis in adults with traumatic brain injury","volume":"48","author":"Caballero","year":"2013","journal-title":"Hosp. Pharm."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108251_bib12","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12028-013-9951-x","article-title":"Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis","volume":"21","author":"Radic","year":"2014","journal-title":"Neurocrit Care"},{"issue":"8","key":"10.1016\/j.clineuro.2024.108251_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40263-016-0365-0","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis following traumatic brain injury: a systematic review and meta-analysis","volume":"30","author":"Yang","year":"2016","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108251_bib14","first-page":"375","article-title":"Cost-utility analysis of Levetiracetam and phenytoin for posttraumatic seizure prophylaxis","volume":"71","author":"Cotton","year":"2011","journal-title":"J. Trauma"},{"key":"10.1016\/j.clineuro.2024.108251_bib15","first-page":"15","article-title":"Cost-effectiveness analysis of intravenous Levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury","volume":"2","author":"Kazerooni","year":"2010","journal-title":"Clin. Outcomes Res"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108251_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/TA.0b013e31823df31f","article-title":"A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury","volume":"72","author":"Pieracci","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108251_bib17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","article-title":"Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study","volume":"47","author":"Ramael","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2024.108251_bib18","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.wneu.2017.11.116","article-title":"Early and late posttraumatic epilepsy in the setting of traumatic brain injury: a meta-analysis and review of antiepileptic management","volume":"110","author":"Wilson","year":"2018","journal-title":"World Neurosurg."},{"issue":"22","key":"10.1016\/j.clineuro.2024.108251_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000296051.34044.07","article-title":"Seizure medications and their side effects","volume":"69","author":"Karceski","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108251_bib20","doi-asserted-by":"crossref","DOI":"10.3171\/FOC.2008.25.10.E3","article-title":"Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury","volume":"25","author":"Jones","year":"2008","journal-title":"Neurosurg. Focus"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108251_bib21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12028-009-9304-y","article-title":"Prospective, randomized, single-blinded comparative trial of intravenous Levetiracetam versus phenytoin for seizure prophylaxis","volume":"12","author":"Szaflarski","year":"2010","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108251_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/TA.0b013e3182826e84","article-title":"A prospective multicenter comparison of Levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis","volume":"74","author":"Inaba","year":"2013","journal-title":"J. Trauma Acute Care Surg."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108251_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2012.11.020","article-title":"Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to Levetiracetam","volume":"28","author":"Kruer","year":"2013","journal-title":"J. Crit. Care"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108251_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3171\/2013.10.PEDS13256","article-title":"Levetiracetam versus (fos)phenytoin for seizure prophylaxis in pediatric patients with intracranial hemorrhage","volume":"13","author":"Bansal","year":"2014","journal-title":"J. Neurosurg. Pedia"},{"issue":"11-12","key":"10.1016\/j.clineuro.2024.108251_bib25","doi-asserted-by":"crossref","first-page":"e3570","DOI":"10.1093\/milmed\/usad192","article-title":"Use of Levetiracetam for post-traumatic seizure prophylaxis in combat-related traumatic brain injury","volume":"188","author":"Atwood","year":"2023","journal-title":"Mil. Med"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108251_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4103\/ajns.AJNS_125_17","article-title":"Comparison of phenytoin versus Levetiracetam in early seizure prophylaxis after traumatic brain injury, at a tertiary care hospital in Karachi, Pakistan","volume":"13","author":"Younus","year":"2018","journal-title":"Asian J. Neurosurg."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108251_bib27","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00268-016-3606-y","article-title":"Levetiracetam prophylaxis for post-traumatic brain injury seizures is ineffective: a propensity score analysis","volume":"40","author":"Zangbar","year":"2016","journal-title":"World J. Surg."},{"issue":"11","key":"10.1016\/j.clineuro.2024.108251_bib28","first-page":"1440","article-title":"Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury","volume":"48","author":"Gabriel","year":"2014","journal-title":"Ann. Pharm."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108251_bib29","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00415-020-09769-5","article-title":"Impact of anti-epileptic drug choice on discharge in acute traumatic brain injury patients","volume":"267","author":"Harris","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108251_bib30","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCC.0000000000002576","article-title":"Early use of antiseizure medication in mechanically ventilated traumatic brain injury cases: a retrospective pediatric health information system database study","volume":"22","author":"Haque","year":"2021","journal-title":"Pedia Crit. Care Med."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108251_bib31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/02699052.2021.1927184","article-title":"Incidence of neurobehavioral side effects associated with levetiracetam compared to phenytoin in traumatic brain injury patients","volume":"35","author":"Nguyen","year":"2021","journal-title":"Brain Inj."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108251_bib32","first-page":"455","article-title":"Comparison of efficacy of phenytoin and Levetiracetam for prevention of early post traumatic seizures","volume":"28","author":"Khan","year":"2016","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"10.1016\/j.clineuro.2024.108251_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jocn.2019.07.066","article-title":"The use of antiepileptic medication in early post traumatic seizure prophylaxis at a single institution","volume":"69","author":"Candy","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108251_bib34","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.clineuro.2024.108251_bib35","doi-asserted-by":"crossref","first-page":"1001363","DOI":"10.3389\/fphar.2022.1001363","article-title":"Effectiveness of antiseizure medications therapy in preventing seizures in brain injury patients: a network meta-analysis","volume":"13","author":"Huo","year":"2022","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108251_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3171\/jns.1999.91.4.0588","article-title":"Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis","volume":"91","author":"Haltiner","year":"1999","journal-title":"J. Neurosurg."},{"issue":"9","key":"10.1016\/j.clineuro.2024.108251_bib37","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2146\/ajhp120203","article-title":"Use of antiepileptics for seizure prophylaxis after traumatic brain injury","volume":"70","author":"Torbic","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.clineuro.2024.108251_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.seizure.2015.10.002","article-title":"Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure","volume":"33","author":"Lucke-Wold","year":"2015","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.clineuro.2024.108251_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:04:16Z","timestamp":1714115056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724001380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"alternative-id":["S0303846724001380"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108251","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Levetiracetam versus phenytoin in preventing seizure in traumatic brain injury patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108251"}}